Clinical trials: Patient-Reported Outcomes
Postoperative Complications
The South African Collaborative Surgical Outcomes Study (SACSOS)
Improving quality of perioperative care depends on reliable measurement of clinically important and patient-centred data, that will allow collaborative decision-making between patient and clinician.
- Trial name
- SACSOS (NCT05052021)
- Testing
- Public or Private Sector Patients
- Volunteers
- 1,000 people
- Sponsor
- Sefako Makgatho Health Sciences University
Stage I Adult Liver Cancer, Stage I Colorectal Cancer
Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery
This pilot clinical trial studies an electronic monitoring device of patient-reported outcomes (PROs) and function in improving patient-centered care in patients with gastrointestinal cancer undergoing surgery.
- Conditions
- Stage I Adult Liver Cancer, Stage I Colorectal Cancer, Stage IA Gastric Cancer, Stage IA Pancreatic Cancer
- Trial name
- NCT02511821
- Testing
- Computer-Assisted Intervention, Vivofit watch, Quality-of-Life Assessment
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- City of Hope Medical Center
Prostate Cancer
Influence of Electronic Patient Reported Outcomes (ePROMs) in Surgical Therapy for Prostate Cancer on Postoperative Outcome
The study investigates the influence of structured follow-up using ePROMS in the 1st year after prostatectomy on the postoperative course.
- Trial name
- PRO-P (NCT05644821)
- Testing
- complex intervention, current clinical practice
- Where
- 5 sites in Germany
- Volunteers
- 260 people
- Sponsor
- Heinrich-Heine University, Duesseldorf
Prostate Cancer
Health-Related Quality of Life in Gay Men With Localized Prostate Cancer
RATIONALE: Gathering information about prostate cancer, treatment, and quality of life from gay men with prostate cancer may help doctors plan the best treatment.
- Trial name
- NCT00828633
- Where
- 3 sites in United States, Canada
- Volunteers
- 92 people
- Sponsor
- Baylor College of Medicine
MPN (Myeloproliferative Neoplasms)
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
The purpose of this prospective, longitudinal, noninterventional study is to describe clinical characteristics, evolution of disease burden, and treatment patterns in patients with select subcategories of essential…
- Trial name
- NCT02953704
- Where
- 116 sites in United States, Puerto Rico
- Volunteers
- 1,469 people
- Sponsor
- Incyte Corporation
Postoperative Recovery in Elderly Patients, Quality of Recovery After Elective Surgery
Postoperative Recovery in Elderly Patients Assessed With QoR-15E
Postoperative recovery in elderly patients is an important part of the surgical process and affects how patients feel after surgery.
- Conditions
- Postoperative Recovery in Elderly Patients, Quality of Recovery After Elective Surgery, Perioperative Care Outcomes in Older Adults
- Trial name
- PQoRE (NCT07505758)
- Testing
- QoR-15E questionnaire., Clinical Frailty Scale, Confusional Assessment Method
- Where
- 4 sites in Spain
- Volunteers
- 600 people
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute
Breast Neoplasm
Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy
In this study the investigators assess the impact of the eHealth-supported therapy management system CANKADO on Quality of Life in patients with HR+, HER2-locally advanced or metastatic breast cancer treated with the cyclin…
- Trial name
- PRECYCLE (NCT03220178)
- Testing
- Palbociclib, Fulvestrant, Anastrozole
- Where
- Germany
- Volunteers
- 532 people
- Sponsor
- Palleos Healthcare GmbH
Deep Bite Malocclusion
Bonded Bite Turbos Were Bonded to Palatal Surfaces of Maxillary Incisors for Sixty Patients With Anterior Deep Overbite to Check Acceptance Rate of Patients to These Bite Turbos.
Background: Bonded composite bite turbos are an efficient tool in the treatment of deep bite malocclusion. Patient satisfaction with orthodontic appliances has been correlated with treatment success.
- Trial name
- ABT-SAT (NCT07143916)
- Testing
- bonded anterior bite turbos
- Where
- Egypt
- Volunteers
- 60 people
- Sponsor
- Cairo University
Osteoarthritis
Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties. A Trial Evaluating Early Component Migration by RSA and Patient Reported Outcome.
In the history of TKA several different types of prosthetic designs have been evolved in order to optimize knee function after total knee replacement.
- Trial name
- NCT01966848
- Testing
- Wich prosthesis is used
- Where
- Denmark
- Volunteers
- 60 people
- Sponsor
- Hvidovre University Hospital
Diabetes Mellitus, Type 1
Insulin Delivery Using the DBLG1 Closed-loop on Glycemic Control and PROMs in Adults Living With Type 1 Diabetes
To evaluate the impact of the DBLG1 hybrid closed-loop system on glycemic control and patient-reported outcomes in adults living with type 1 diabetes under real-life conditions.
- Trial name
- INLOOP (NCT06154135)
- Where
- 12 sites in Belgium
- Volunteers
- 165 people
- Sponsor
- Erasme University Hospital
Pain, Post Operative Pain
Patient Reported Outcomes, Postoperative Pain and Pain Relief After Day Case Surgery (POPPY)
Around 3 out of 4 operations in the UK are performed as day-case, meaning the patient goes home on the same day of their operation.
- Conditions
- Pain, Post Operative Pain, Opioid Use, Chronic Pain
- Trial name
- POPPY (NCT06008496)
- Testing
- Day case surgery
- Where
- United Kingdom
- Volunteers
- 7,839 people, healthy volunteers welcome
- Sponsor
- University Hospital Plymouth NHS Trust
Myelodysplastic Syndrome (MDS)
Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan
This study will examine quality of life, experiences, and unmet needs among individuals diagnosed with Low Risk Myelodysplastic Syndrome who are erythropoietin stimulating agent naïve and non-transfusion dependent and among…
- Trial name
- NCT07008820
- Testing
- Health-related quality of life questionnaires, Qualitative interviews
- Where
- Japan
- Volunteers
- 56 people
- Sponsor
- Bristol-Myers Squibb
Atrial Fibrillation
Patient-reported Outcome Follow-up Based on the Northern Shanghai Community Chronic Disease Management System
Influence of patient-reported outcome follow-up based on the northern Shanghai community chronic disease management system on the follow-up compliance and satisfaction of patients with atrial fibrillation after cryoablation.
- Trial name
- NCT05511662
- Testing
- PRO follow up
- Where
- China
- Volunteers
- 240 people
- Sponsor
- Shanghai 10th People's Hospital
Gout, Rheumatoid Arthritis
Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
Inflammatory rheumatic diseases affect 1% of the population. Treatment of such diseases should be based on disease activity, safety issues and other patient characteristics such as comorbidities (EULAR, 2022), leading to a higher…
- Conditions
- Gout, Rheumatoid Arthritis, Sjogren's Syndrome, Systemic Lupus Erythematosus
- Trial name
- CAPTAIN (NCT05927688)
- Testing
- Therapeutic management following access by the physician to his patient's ePROs
- Where
- France
- Volunteers
- 352 people
- Sponsor
- University Hospital, Strasbourg, France
Epilepsy
Tele-patient-reported Outcomes (telePRO) in Clinical Practice
The aim of this study is to compare quality of care and patient experiences in two outpatients follow-up activities: 1) Standard telePRO (fixed interval telePRO follow-up) and 2) Open Access telePRO (patient-initiated telePRO…
- Trial name
- NCT02673580
- Testing
- Open Access telePRO, Standard telePRO
- Where
- Denmark
- Volunteers
- 593 people
- Sponsor
- University of Aarhus
Esophageal Cancer, Patient-reported Outcomes
Dynamic Follow-up of Symptoms Based on Patient-reported Outcomes in Immunotherapy for Esophageal Cancer: a Prospective Multicentre Cohort Study (SPRING)
Immunotherapy shows satisfactory effectiveness and safety in patients with esophageal cancer. Immunotherapy-based regimens have a better survival benefit compared to previous chemotherapy and radiotherapy.
- Conditions
- Esophageal Cancer, Patient-reported Outcomes, Immunotherapy
- Trial name
- NCT06012318
- Where
- China
- Volunteers
- 220 people
- Sponsor
- Guangdong Provincial People's Hospital
HIV
Chemsex Health Evaluation With Extended Release System for HIV Treatment
CHEERS is an observational cohort for people living with HIV who are actively practicing chemsex and who are switching to CAB + RPV LA after being virologically suppressed on a stable oral ART regimen.
- Trial name
- CHEERS (NCT06565013)
- Testing
- Cabenuva 600/900, Self administered questionnaires, Semi-directed interview
- Where
- Canada
- Volunteers
- 50 people
- Sponsor
- Clinique Médicale L'Actuel
Kidney Disease, End-Stage
Electronic Patient-Reported Outcomes in Clinical Kidney Practice (ePRO Kidney)
People living with end-stage kidney disease (ESKD) need dialysis or transplantation in order to stay alive. This illness and treatment significantly impact peoples' health, emotions, work and relationships.
- Trial name
- NCT03149328
- Testing
- Educational Support
- Where
- 2 sites in Canada
- Volunteers
- 594 people, healthy volunteers welcome
- Sponsor
- University of Alberta
Acromegaly
Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
Octreotide capsule is a novel, orally-administered formulation of the commercially-available injectable drug octreotide. In a recent phase 3 trial (OPTMAL; NCT03252353), oral octreotide capsules demonstrated sustained biochemical…
- Trial name
- MPOWERED (NCT02685709)
- Testing
- Octreotide capsules
- Where
- 53 sites in United States, Austria and 11 more
- Volunteers
- 146 people
- Sponsor
- Chiasma, Inc.
M-health, Multiple Sclerosis
haMSter: a Novel Smartphone Communication Tool for People With MS
haMSter is a smartphone app that tracks validated patient reported outcome measures (PROMs) in people multiple sclerosis (MS). In this study, 50 patients with MS will receive this app for 6 months and be asked to fill out the PRO…
- Trial name
- NCT04555863
- Testing
- haMSter smartphone app
- Where
- Austria
- Volunteers
- 50 people
- Sponsor
- Medical University of Vienna
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.